# The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation

> **NCT03887377** · PHASE2,PHASE3 · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 22 (actual)

## Conditions studied

- Scar
- Hypertrophic Scar
- Mammary Disorder

## Interventions

- **DRUG:** Botulinum Toxins
- **OTHER:** Normal saline

## Key facts

- **NCT ID:** NCT03887377
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-10
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03887377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03887377, "The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03887377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*